Tested Applications
| Positive WB detected in | HeLa cells, MCF-7 cells, RAW 264.7 cells, HepG2 cells, mouse ovary tissue |
| Positive IHC detected in | human ovary cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:5000-1:50000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
27500-1-AP targets DDX41 in WB, IHC, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag26593 Product name: Recombinant human DDX41 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-144 aa of BC015476 Sequence: MEESEPERKRARTDEVPAGGSRSEAEDEDDEDYVPYVPLRQRRQLLLQKLLQRRRKGAAEEEQQDSGSEPRGDEDDIPLGPQSNVSLLDQHQHLKEKAEARKESAKEKQLKEEEKILESVAEGRALMSVKEMAKGITYDDPIKT Predict reactive species |
| Full Name | DEAD (Asp-Glu-Ala-Asp) box polypeptide 41 |
| Calculated Molecular Weight | 70 kDa |
| Observed Molecular Weight | 70 kDa |
| GenBank Accession Number | BC015476 |
| Gene Symbol | DDX41 |
| Gene ID (NCBI) | 51428 |
| RRID | AB_2880891 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9UJV9 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
DDX41, also named as DEAD box protein abstrakt homolog, is a 622 amino acid protein, which is a probable ATP-dependent RNA helicase. DDX41 is required during post-transcriptional gene expression.and may be involved in pre-mRNA splicing.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for DDX41 antibody 27500-1-AP | Download protocol |
| WB protocol for DDX41 antibody 27500-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
DDX41 antibody (Cat# 27500-1-AP) has 3 total citations. These appear in NPJ Precision Oncology, Journal of Translational Medicine, and British Journal of Cancer. The research fields span head and neck squamous cell carcinoma (immune escape via STING pathway), Parkinson's disease (microglia-mediated neuroinflammation), and ovarian cancer (malignant progression through intron retention). Applications include Western blot and immunohistochemistry in human and mouse samples.
| Species | Application | Title |
|---|---|---|
NPJ Precis Oncol DDX41 facilitates PD-L1-mediated immune escape in OSCC via the phase separation and activation STING pathway.
| ||
J Transl Med MicroRNA-218-5p-Ddx41 axis restrains microglia-mediated neuroinflammation through downregulating type I interferon response in a mouse model of Parkinson's disease | ||
Br J Cancer Spliceosomal GTPase EFTUD2 mediates DDX41 intron retention to promote the malignant progression of ovarian cancer |







